SCHEMBL409419

SCHEMBL409419

CCOC(=O)C(N)OCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4281970 0.78 ALOX15 (0.46)
SCHEMBL10636646 0.78
SCHEMBL9135135 0.75
SCHEMBL2443209 0.75
SCHEMBL338079 0.74 ALOX15 (0.52)
SCHEMBL22469854 0.74
SCHEMBL135308 0.72
SCHEMBL372610 0.72
SCHEMBL196408 0.72
Hydrochloric Acid SCHEMBL275716 0.72 ALOX15 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113463398-A Preparation method of black hole external composite functional powder and textile after-finishing liquid 聚治(苏州)纳米科技有限公司 2021-10-01 CN claimed
US-20210157242-A1 PHOTORESIST-REMOVING LIQUID AND PHOTORESIST-REMOVING METHOD HUAYING RESEARCH CO., LTD (CN) 2021-05-27 US claimed
EP-3663857-A1 PHOTORESIST STRIPPING SOLUTION AND METHOD OF STRIPPING PHOTORESIST Huaying Research Co., Ltd (CN) 2020-06-10 EP claimed
EP-3980400-B1 PEPTIDOMIMETICS FOR THE TREATMENT OF CORONAVIRUS AND PICORNAVIRUS INFECTIONS UNIV EMORY (US) 2025-08-06 EP disclosed
US-12268723-B2 Peptidomimetics for the treatment of coronavirus and picorna virus infections EMORY UNIVERSITY (US) 2025-04-08 US disclosed
EP-3885340-B1 ANDROGEN RECEPTOR MODULATING COMPOUNDS ORION CORP (FI) 2024-11-27 EP disclosed
US-11448966-B2 Photoresist-removing liquid and photoresist-removing method HUAYING RESEARCH CO., LTD (CN) 2022-09-20 US disclosed
US-20220273753-A1 PEPTIDOMIMETICS FOR THE TREATMENT OF CORONAVIRUS AND PICORNAVIRUS INFECTIONS EMORY UNIVERSITY 2022-09-01 US disclosed
EP-3980400-A1 PEPTIDOMIMETICS FOR THE TREATMENT OF CORONAVIRUS AND PICORNAVIRUS INFECTIONS Emory University (US) 2022-04-13 EP disclosed
US-11207370-B2 Peptidomimetics for the treatment of coronavirus and picornavirus infections EMORY UNIVERSITY (US) 2021-12-28 US disclosed
EP-3885340-A1 ANDROGEN RECEPTOR MODULATING COMPOUNDS ORION CORPORATION (FI) 2021-09-29 EP disclosed
WO-1994014782-A1 4-BENZOYL ISOXAZOLES DERIVATIVES AND THEIR USE AS HERBICIDES RHONE-POULENC AGRICULTURE LTD. (GB) 1994-07-07 WO disclosed
US-5284853-A Hypotensive agents AMERICAN CYANAMID COMPANY (US) 1994-02-08 US disclosed
US-5273989-A 3,5-disubstituted 2-isoxazolines and isoxazoles, agents containing them and their use HOECHST AKTIENGESELLSCHAFT (DE) 1993-12-28 US disclosed
US-5258397-A FOR TREATMENT OF EPILEPSY; SIDE EFFECT REDUCTION NOVAPHARME (FR) 1993-11-02 US disclosed
EP-0487357-A1 4 Benzoyl isoxazole derivatives RHONE-POULENC AGRICULTURE LTD. (GB) 1992-05-27 EP disclosed
US-5108999-A For treating inflammation, autoimmune disease or allograft rejection in mammals SYNTEX (U.S.A.) INC. (US) 1992-04-28 US disclosed
WO-1992003050-A1 FUNGICIDAL SULFONEOXIME ESTERS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1992-03-05 WO disclosed
EP-0440503-A1 4-Isoxazolecarboxamide derivatives SYNTEX (U.S.A.) INC. (US) 1991-08-07 EP disclosed
US-5001124-A 4-isoxazolecarboxamide derivatives SYNTEX (U.S.A.) INC. (US) 1991-03-19 US disclosed